Summary & Overview
CPT 0444T: Drug‑Eluting Ocular Device Placement for Glaucoma
CPT code 0444T represents placement of a drug-eluting ocular device — a clear, flexible contact-lens‑like implant placed under the eyelid to deliver medications such as timolol for glaucoma control. The code covers the fitting, patient training, and initial insertion for one or both eyes. This therapy is clinically significant as it offers sustained intraocular pressure management through localized drug delivery, which can affect treatment pathways for glaucoma nationally.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code covers, typical clinical settings and service lines, and the types of benchmarks and policy considerations commonly associated with novel ophthalmic drug-delivery procedures. The publication outlines payment and coding contexts, common modifiers used in practice, and clinical implications for glaucoma management. It also identifies where input data is not available and highlights areas—such as associated taxonomies and ICD-10 diagnoses—marked as not provided in the source. The summary is intended for billing professionals, clinical managers, and policy analysts seeking a national-level brief on CPT code 0444T.
Billing Code Overview
CPT code 0444T describes placement of a clear, flexible ocular device that functions similarly to a contact lens and contains a drug (for example, timolol) for treatment of glaucoma. The procedure includes fitting the device, training the patient, and the initial insertion into one or both eyelids.
-
Service type: Office-based or ambulatory ophthalmic therapeutic procedure involving drug-delivery ocular device placement, including patient education and device fitting.
-
Typical site of service: Ophthalmology clinic, outpatient surgery center, or other ambulatory care setting where ophthalmic procedures are performed.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with primary open-angle glaucoma attends an ophthalmology clinic for management of elevated intraocular pressure despite maximally tolerated topical drops. The ophthalmologist evaluates vision, intraocular pressure (IOP), slit-lamp exam, and optic nerve status, and recommends placement of a sustained-release ocular insert (drug-eluting punctal or conjunctival device similar to a contact lens) containing a glaucoma medication such as timolol. The clinical workflow includes pre-procedure counseling, informed consent, measurement of IOP and corneal status, fitting and selection of the appropriately sized device, instruction and training on device care and signs of complications, and initial insertion in the office under topical anesthesia. Post-insertion observation verifies device position and immediate tolerance; follow-up visits monitor IOP response, device retention, and ocular surface health. Typical site of service is an ophthalmology office or ambulatory surgery center for outpatient insertion and training.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the work, time, or technical difficulty of device fitting/insertion is substantially greater than typical. |
52 | Reduced services | Use when the device insertion is partially completed or a reduced service is provided. |
53 | Discontinued procedure | Use when the insertion is started but halted due to patient instability or intolerable reaction. |
54 | Surgical care only | Use when only the provider performs the insertion and another practitioner provides pre/postoperative care (rare in office-based insertion). |
55 | Postoperative care only | Use when another surgeon performed the insertion and the reporting provider only manages postoperative care. |
62 | Two surgeons | Use when two surgeons with distinct roles perform the procedure concurrently. |
66 | Surgical team | Use when the procedure is performed by a surgical team with separate responsibilities. |
73 | Discontinued outpatient hospital/ambulatory surgery before anesthesia | Use if the patient is prepared for an ASC procedure but it is cancelled before anesthesia for this device. |
78 | Return to operating/procedure room for related procedure during postoperative period | Use if a subsequent procedure is required to reposition or replace the device during the global period. |
80 | Assistant surgeon | Use if an assistant surgeon is required for the insertion. |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services in lieu of the physician | Use when a qualified non-physician practitioner performs the insertion under appropriate supervision per payor rules. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207W00000X | Ophthalmology | Primary specialty performing glaucoma device insertion and postoperative management. |
| 103T00000X | Ophthalmic Plastic and Reconstructive Surgery | May perform advanced ocular surface or lid-related device placements. |
| 363A00000X | Optometry | May participate in device fitting and follow-up where state scope and payor policies permit. |
| 354H00000X | Anesthesiology | Involvement uncommon; topical anesthesia typically used, but anesthesia support may be listed for ASC cases. |
| 207L00000X | Retina/Vitreous Specialist (Ophthalmology sub-specialty) | In practices where glaucoma specialists collaborate for complex anterior segment device management. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
H40.10 | Unspecified open-angle glaucoma | Common indication for sustained-release topical intraocular pressure–lowering devices. |
H40.11 | Primary open-angle glaucoma | Primary diagnosis targeted by glaucoma drug-delivery devices such as timolol inserts. |
H40.13 | Low-tension glaucoma | Device may be used in patients with progressive optic neuropathy despite normal-range IOP. |
H40.221 | Primary open-angle glaucoma, moderate stage | Used to describe disease severity when considering interventional sustained-delivery therapy. |
H40.223 | Primary open-angle glaucoma, severe stage | Advanced disease where alternative delivery methods may be considered to improve adherence. |
H40.30 | Angle-closure glaucoma, unspecified | Included as related glaucoma diagnosis when alternative surgical or device approaches are evaluated. |
H11.39 | Other conjunctival degenerations | Relevant when ocular surface health may affect device retention and tolerance. |
H02.83 | Lagophthalmos | Eyelid dysfunction that can affect device placement and retention. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
92083 | Diagnostic ophthalmological services; extended ophthalmoscopy and intraocular pressure measurement with interpretation and report (per visit) | Often performed before and during follow-up to document IOP response to the implanted drug-eluting device. |
99213 | Office or other outpatient visit for the evaluation and management of an established patient, low to moderate complexity | Typical E/M code for pre-procedure assessment or routine postoperative follow-up visits in the office. |
66821 | Excision of lesion of eyelid, full-thickness, repair of defect; simple | Performed rarely if device-related complications require surgical removal of conjunctival or eyelid tissue. |
65855 | Removal of implanted ocular device from the conjunctival sac | Used when the drug-eluting device requires removal or replacement after initial insertion. |
67028 | Intravitreal injection of a pharmacologic agent | Different route of ocular drug delivery; may be used in alternative or adjunctive glaucoma pharmacotherapy strategies. |